Press release: Abcam and TTP Labtech Collaborate to Develop sol-R Reagent Kits
Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research
Cambridge, UK, 16th August 2017: TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, and Abcam plc, a global innovator in life sciences reagents and tools, today announced a collaboration to further develop reagent kits for the quantification of secreted proteins in multiplexed screening assays.
Following the successful launch last year of sol-R coded beads, TTP Labtech is working with Abcam to meet customer needs by developing assay ready kits which enable researchers to deliver data driven decisions faster and with confidence. The sol-R reagent kits will offer Abcam’s highly validated and quality assured antibodies including recombinant antibody pairs, combined with the reliability of sol-R coded beads and mirrorball® fluorescence cytometry technology from TTP Labtech for sample analysis.
Joby Jenkins, director – product strategy, TTP Labtech, commented: “Our sol-R coded beads are designed for secreted protein quantification in multiplexed no-wash immunoassay screens. Working with Abcam on the development of the sol-R reagent kits enables us to combine their advanced antibody technology and reagent expertise with our sol-R bead technology to provide convenient off-the-shelf kits. Since the kits are validated on TTP Labtech’s mirrorball plate-based fluorescent cytometer, repeated wash steps associated with traditional sandwich ELISA’s are no longer necessary, thereby significantly reducing assay times, while delivering data integrity.”
John Baker, Senior Vice President Portfolio and Business Development, at Abcam, said: “The integration of Abcam’s high quality antibody technology with
TTP Labtech’s sol-R Reagents will deliver reproducibility, quality and efficiency to life science researchers, accelerating their research. The new kits have been designed for researchers carrying out high-throughput immunoassays including drug discovery in biotech, pharma and contract research organisations.”
TTP Labtech will offer Alexa Fluor® technology1, one of the most frequently cited and trusted fluorochromes, with the kits to ensure the quality of the fluorescent signal produced by the kits. The kits will be available globally through the TTP website and their authorised distributors, alternatively register at http://ttplabtech.com/landing/sol-r-reagents/ to apply for TTP Labtech’s early access program.
The new sol-R reagent kits will be released at MipTec 2017, Basel, 11-13th September – customers should visit booth #A26 to find out more.
- Alexa Fluor 488 (AF488) Streptavidin, licensed by Thermo Fisher Scientific.
For further information please contact:
Tel: +44 (0)7811 996 942
For Abcam Media enquires please contact:
Dr. Priya Kalia / Dr. Lynne Trowbridge
T: +44 (0)20 7866 7862 / +44 (0)20 7457 2861
About TTP Labtech http://ttplabtech.com/
TTP Labtech designs and manufactures robust, reliable and easy-to-use solutions for sample management, liquid handling and multiplexed detection in drug discovery and genomics. We enable life scientists, through collaboration, deep application knowledge and leading engineering, to accelerate research and make a difference together. Our essential tools include state-of-the-art solutions developed for high throughput compound and biologics screening (acumen® Cellista, mirrorball® and fully validated consumables such as sol-R™ beads and plates),flexible sample management workflows from ambient to -800C (comPOUND®, arktic®, lab2lab), and unique low-volume liquid handling for genomics, compound screening and protein crystallography (mosquito® X1, mosquito® HTS, mosquito® crystal, mosquito® LCP, mosquito® HV, dragonfly® crystal and dragonfly® discovery and a full range of validated consumables such as tips and plates).
About Abcam plc www.abcam.com
As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, Abcam offers highly validated biological binders and assays to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcam’s ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world’s 750,000 life science researchers use Abcam’s affinity binders, reagents, biomarkers, and assays, and the company’s products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences.
By actively listening to and collaborating with researchers, Abcam continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.
Abcam’s twelve locations are located in the world’s leading life science research hubs, enabling local services and multi-language support. Founded in 1998 and headquartered in Cambridge, UK, the company sells to more than 100 countries. Abcam was admitted to AIM in 2005 (AIM: ABC).